Karnataka stares at power crisis in next 20 days

Bengaluru, Apr 14: Karnataka Chief Minister BS Yediyurappa on Tuesday welcomed Prime Minister Narendra Modi's decision to extend COVID-19 lockdown till May 3.

"Our government will strictly implement the Government of India guidelines, which will be issued tomorrow. Lockdown will be followed more stringently till April 20 as Prime Minister said and the situation will be closely monitored. I appeal to the people of Karnataka to voluntarily cooperate with us to contain this disease," Yediyurappa said.

The chief minister urged the people to respect seven major points that Prime Minister Modi raised in his televised address to the nation on Tuesday, while announcing the extension of coronavirus-induced lockdown.

"I appeal to people to follow the seven measures Prime Minister advised to follow, such as taking care of elders in the house especially those suffering from chronicle illness; strictly maintaining social distancing; enhancing immunity by following guidelines of Ayush Department; download Arogyasetu app; help the poor and needy; to be considerate about your colleagues and employees and not to sack them; and respect the police, healthcare professionals," Yediyurappa added.

The chief minister also assured that there is no scarcity of medicines, essential services and goods.

"We will make all efforts to carry out agriculture activities without any hurdle. I make a special appeal to migrant labours to stay wherever they are and be safe... Stay home and be safe," he said.

According to the Union Ministry of Health and Family Welfare, there are 247 COVID-19 positive cases in Karnataka including 59 cured, discharged, migrated and six deaths.

Bengaluru, Apr 15: Karnataka and five other states have their coronavirus antibody test kits stuck in China because of the country's new policy of getting clearance from their government before a company exports its products.

Singapore-based Sensing Self Ltd and China’s Wondfo are the only companies that have cleared Pune's National Institute of Virology (NIV)’s validation for rapid antibody test kit.

Dr CN Manjunath, Director, Jayadeva Institute of Cardiovascular Sciences and Research, and nodal officer for COVID-19 lab testing, Karnataka, said, "Inventory is ready in Hong Kong Airport. Karnataka's consignment is stuck with five other states' consignments: Kerala, Andhra Pradesh, Rajasthan, Gujarat, and Meghalaya. On April 1 or 3, China's policy changed saying any exports going out of China has to be certified by the Chinese government."

Bengaluru, Mar 11: The Insurance Regulatory Authority of India has asked insurers to settle all claims related to coronavirus expeditiously under existing health policies that provide for treatment of hospitalisation expenses.

It has also asked insurers to design products covering the cost of treatment of coronavirus that has fast spread across the world and also resulted in increasing number of infections in India. There has been over 3,000 deaths globally and 58 cases tested positive in India.

In order to provide need-based health insurance coverage, insurers are intro ducing products for various specific diseases, including vector borne diseases. "For the purpose of meeting health insurance requirements of various sections, insurers are advised to design products covering the costs of treatment for coronavirus," the IRDAI said in a circular.

The regulator said that under existing health insurance policies where hospitalisation is covered, not only the cases related to coronvirus disease (COVID-19) shall be expeditiously handled, but all the costs of admissible medic al expenses during the course of treatment, including the treatment during quarantine period, should be settled in accordance to the applicable terms and conditions of policy contract and the extant regulatory framework.

This would bring much needed relief to policy holders some of whom were facing difficulty in getting coverage for treatment takers to coronavirus. In the absence of clear information, a few hospitals were reportedly denying for forward such claims of policy holders to the insurers.

IRDAI has now said that all the claims reported under COVID-19 shall be thoro ughly reviewed by review committee before repudiating the claims. This would prevent blanket rejection of such claims.

But to get full claim for treatment of coronavirus, industry experts said, a person should be hospitalised at least for 24 hours. Most insurers do not c over outpatient treatment.